medigraphic.com
SPANISH

Gaceta Médica de México

ISSN 0016-3813 (Print)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2002, Number S1

<< Back Next >>

Gac Med Mex 2002; 138 (S1)

Pediatric Hepatology

I. Prognostic Factors in Fanconi Anemia.
II. Impact of Folate and Iron Deficiency in the Mother-Child Binome.
III. Wiskott-Aldrich Syndrome.

Pompa-Garza T, Nieto-Martínez SA, Alvarez-Amaya C
Full text How to cite this article

Language: Spanish
References: 28
Page: 78-82
PDF size: 45.54 Kb.


Key words:

No keywords

Text Extraction

No abstract


REFERENCES

  1. Butturini A Gale RP. Hematologic abnormalities in Fanconi anemia: an International FA Registry Study. Blood 1994;84:1650-1655.

  2. Sieff CA. Congenital bone marrow failure syndromes. Br J Haematol 2000;111,30-42.

  3. Alter BP. Fanconi’s anemia and its variability. Br J Haematol 1993 ;85:9-14.

  4. Alter BP. Frissora CH. Fanconi’s anemia and pregnancy. Br J Hematol 1991;77:410-418.

  5. Dupuis-Giros S, Glluckman E. Growth hormone deficiency caused by pituitary stalk interruption in FA. J Pediatr 2001:138:129-133.

  6. Botto LD, Moore CA, Khoury RJ, Erickson JD. Neural-tube defects. Review. N Eng J Med 1999;341(20):1509-1519.

  7. Azaola P, Navarreta JI. Patología de la deficiencia de ácido fólico. En: Enciclopedia Iberoamericana de Hematología. Salamanca. Editorial Universidad, 1992. p. 276-282.

  8. Van der Put NM, Blom HJ. Neural tube defects and disturbed folate dependent homocysteine metabolism. Eur J Obstet Gynecol Reprod Biol 2000;1,92 (1): 57-61.

  9. Mutchinick OM, López MA, Luna L, Waxman J, Babinsky VE. High prevalence of the thermolabile methylenetetrahydrofolate reductasa variant in Mexico: a country with a very high prevalence of Neural Tube Defects. Mol Gen Met 1999;68:461-467.

  10. Subsecretaría de Prevención y Control de Enfermedades, SS. Proyecto de la Norma Oficial Mexicana para la Prevención y Control de los Defectos al Nacimiento. México: Proy NOM-034-SSA2-2000.

  11. Olivé A. Ferropenia y anemia ferropriva de los niños. Estudio clínico y terapéutico. Barcelona, España. Editorial JIMS, 1977.

  12. Walter T, De Andraca I, Chadud P, Perales CG. Iron deficiency anemia: adverse effects on infant psychomotor development. Pediatrics 1989;84:7-17.

  13. Walter T. Impacto de la deficiencia de hierro en el estado cognoscitivo en la lactancia y la niñez. Eur J Clin Nutr 1993;47: 307-316.

  14. Lozoff B, Jiménez E, Wolf AW. Long-term developmental outcome of infants with iron deficiency. N Engl J Med 1991;325: 687-694.

  15. Wiskott A. Familiärer Angeborener Morbus Werlhofii? Mschr Kinderheilk 1937;68:212.

  16. Aldrich RA, Steinberg AG, Campbell DC. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eccematoid dermatitis and bloody diarrhea. Pediatrics 1954;13:133.

  17. Canales ML, Mauer AM. Sex-linked hereditary thrombocytopenia as a variant of Wiskott-Aldrich as isolated thrombocytopenia. N Engl J Med 1967;277:899-901.

  18. Álvarez-Amaya C, Dorantes MS, Toro PHA, et al. Forma atenuada del síndrome de Wiskott-Aldrich y la trascendencia de su identificación en el pronóstico de la esplenectomía. Bol Med Hosp Inf Mex 1969;26:633-47.

  19. Dorantes MS. Diagnóstico de los problemas hematológicos en pediatría. Segunda edición. México: Ed. Med. Hosp Infant Mex; 1997.

  20. Ochs HD, Slichter SU, Harker LA. Von Behrens WE, Clark RA, Wedgwood RJ. The Wiskott-Aldrich syndrome: studies of lympho-cytes, granulocytes, and plaquetas.Blood 1980;55:243-252.

  21. Litzman J, Jones A, Hann I, et al. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. Arch Dis Child 1996;75:436-39.

  22. Laborde BG, Huerta ME, Cortés GM, Tello GA. Síndrome de Wiskott-Aldrich. Bol Med Hosp Infa Mex 1995;52:256-61.

  23. Brickell PM, Katz DR, Thrasher AJ. Wiskott-Aldrich syndrome: current research concepts. Br J Haematol 1998;101:603-08.

  24. Ozsahin H, Le Deist F, Benkerrou M, et al. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center. J Pediatr 1996;129:238-44.

  25. Akman IO, Ostrov BE, Neudorf S. Autoimmune manifestations of the Wiskott-Aldrich syndrome. Semin Arthritis Rheum 1998;27: 218-25.

  26. Rocha V, Wagner JE, Sobocinski KA, et al. Graft-versus host disease in children who have received a cord-blood or bone marrow transplant from a HLA-identical sibling. N Engl J Med 2000;342:1846-54.

  27. Osch HD. The Wiskott-Aldrich syndrome. Semin Hematol 1998;35:332-45.

  28. El-Hakeh J, Rosenzeig S, Oleastro M, et al. Wiskott-Aldrich syndrome in Argentina: 17 unique, including nine novel, mutations. Hum Mutat 2002;19:186-7.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Gac Med Mex. 2002;138